RT @GeorgeVasquezR2: An opportune time to review SGLT21, mechanistic data & clinical implications based on recent trials. My first collab w…
RT @GeorgeVasquezR2: An opportune time to review SGLT21, mechanistic data & clinical implications based on recent trials. My first collab w…
RT @ISMMSKidney: #SGLT2i: Emerging Roles in the Protection Against Cardiovascular and #Kidney Disease Among Patients with #Diabetes @Georg…
RT @ISMMSKidney: #SGLT2i: Emerging Roles in the Protection Against Cardiovascular and #Kidney Disease Among Patients with #Diabetes @Georg…
RT @GeorgeVasquezR2: An opportune time to review SGLT21, mechanistic data & clinical implications based on recent trials. My first collab w…
#SGLT2i: Emerging Roles in the Protection Against Cardiovascular and #Kidney Disease Among Patients with #Diabetes @GeorgeVasquezR2 @girish_nadkarni https://t.co/uLiWtZ1NQK https://t.co/v8NLdJZZE4
An opportune time to review SGLT21, mechanistic data & clinical implications based on recent trials. My first collab w/my boss @girish_nadkarni . Great way to finish my day at the VA @scoca1 @aishaikh @ISMMSKidney https://t.co/qsUBzd9u5D